Back to Journals » Drug, Healthcare and Patient Safety

Drug, Healthcare and Patient Safety


ISSN: 1179-1365

Editor-in-Chief: Professor Rajender Aparasu

An international, peer reviewed, open access journal exploring patient safety issues in the healthcare continuum from diagnostic and screening interventions through to treatment, drug therapy and surgery. The journal is characterized by the rapid reporting of reviews, original research, clinical, epidemiological and post-marketing surveillance studies, risk management, health literacy and educational programs across all areas of healthcare delivery. Also, guidelines on data requirements to assure acceptable safety levels in license applications, and post marketing protocols on monitoring safety on managing associated morbidity and mortality are key topics. Adverse reaction case reports, animal and in vitro toxicity studies are also welcome. Balancing risk, effectiveness, patient satisfaction and quality of life and the development and testing of new interventions to optimize clinical outcomes in disease management are major areas of interest for the journal.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

 

Latest articles:

- 5 records -

Reduction of In-Hospital Preoperative Waiting Time of Elective Surgeries in the Amidst of COVID-19 Pandemic: Experience from Ethiopia

Teklewold B, Abebe E, Anteneh D, Haileselassie E

Drug, Healthcare and Patient Safety 2022, 14:185-194

Published Date: 17 October 2022

Epidemiology of Snake Bites Linked with the Antivenoms Production in Colombia 2008–2020: Produced Vials Do Not Meet the Needs

Estrada-Gómez S, Vargas-Muñoz LJ, Higuita-Gutiérrez LF

Drug, Healthcare and Patient Safety 2022, 14:171-184

Published Date: 29 September 2022

Opioid Utilization and Management in the Setting of Stewardship During Inpatient Rehab Care

Murphy L, Leblanc K, Badr S, Ching E, Mao L, Steenhof N, Hamandi B, Rubin B, Seto A, Furlan AD

Drug, Healthcare and Patient Safety 2022, 14:161-170

Published Date: 11 September 2022

Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Raina R, Houry A, Rath P, Mangat G, Pandher D, Islam M, Khattab AG, Kalout JK, Bagga S

Drug, Healthcare and Patient Safety 2022, 14:147-159

Published Date: 8 September 2022

Describing and Quantifying Wrong-Patient Medication Errors Through a Study of Incident Reports

Takahashi M, Okudera H, Wakasugi M, Sakamoto M, Shimizu H, Wakabayashi T, Yamanouchi T, Nagashima H

Drug, Healthcare and Patient Safety 2022, 14:135-146

Published Date: 23 August 2022


Read more articles